文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

极高龄急性呼吸衰竭患者无创通气的结局:一项回顾性研究

Outcomes of non-invasive ventilation in 'very old' patients with acute respiratory failure: a retrospective study.
PubMed 文献 · Emerg Med J · 2019-04-03
一句话结论在急诊中间监护病房,≥85岁急性呼吸衰竭患者接受无创通气后死亡率与较年轻患者无显著差异,且观察死亡率低于SAPS II预测死亡率。

该回顾性观察研究纳入2015年1月至12月入住卡塔尼亚大学医院急诊科中间监护病房并接受无创通气治疗呼吸衰竭的所有患者,比较≥85岁极高龄患者与较年轻患者的结局。极高龄组平均年龄87.9±2.9岁,平均SAPS II为50.1±13.7,无创通气失败率21.7%。极高龄组死亡率与较年轻组无统计学差异(20% vs 25.6%;差值5.6%;95%CI -8%至19%;p=0.404)。两组观察死亡率均显著低于SAPS II预测死亡率(≥85岁组20.0% vs 43.4%,差值23.4%,95%CI 5.6%至41.1%,p=0.006;较年轻组25.6% vs 38.5%,差值12.9%,95%CI -0.03%至25.8%,p=0.046)。

要点

  • ≥85岁急性呼吸衰竭患者接受无创通气后死亡率20%,与较年轻组25.6%无统计学差异(差值5.6%;95%CI -8%至19%;p=0.404)。
  • ≥85岁组观察死亡率20.0%显著低于SAPS II预测死亡率43.4%(差值23.4%;95%CI 5.6%至41.1%;p=0.006)。
  • 较年轻组观察死亡率25.6%低于预测死亡率38.5%(差值12.9%;95%CI -0.03%至25.8%;p=0.046)。
  • 极高龄组无创通气失败率为21.7%。
  • 两组中因慢性阻塞性肺疾病接受无创通气者死亡率低于其他疾病者,但仅在较年轻组有统计学意义。

适用人群与场景

  • 2015年1月至12月入住卡塔尼亚大学医院急诊科中间监护病房(IMC)并接受无创通气治疗呼吸衰竭的所有患者。
  • 极高龄组定义为年龄≥85岁,与较年轻患者比较。

研究设计与关键结果

  • 研究类型为回顾性观察研究,纳入2015年1月至12月入住急诊科中间监护病房接受无创通气治疗呼吸衰竭的患者,比较≥85岁组与较年轻组的结局。
  • 极高龄组平均年龄87.9±2.9岁,男女比约1:3,平均SAPS II为50.1±13.7。
  • 无创通气失败率为21.7%。
  • 极高龄组死亡率20% vs 较年轻组25.6%,差值5.6%(95%CI -8%至19%),p=0.404,无统计学差异。
  • ≥85岁组观察死亡率20.0% vs SAPS II预测死亡率43.4%,差值23.4%(95%CI 5.6%至41.1%),p=0.006。
  • 较年轻组观察死亡率25.6% vs SAPS II预测死亡率38.5%,差值12.9%(95%CI -0.03%至25.8%),p=0.046。
  • 两组中因慢性阻塞性肺疾病接受无创通气者死亡率低于因其他疾病接受无创通气者,但仅在较年轻组有统计学意义。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在极高龄患者中,当无创通气使用指征正确时,其死亡率与较年轻患者相似。
  • 作者指出,所有年龄组接受无创通气的患者观察死亡率均低于预期死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Non-invasive ventilation (NIV) is increasingly used to support very old (aged ≥85 years) patients with acute respiratory failure (ARF). This retrospective observational study evaluated the impact of NIV on the prognosis of very old patients who have been admitted to the intermediate care unit (IMC) of the Emergency Department of the University Hospital Policlinico-Vittorio Emanuele of Catania for ARF.

METHODS: All patients admitted to the IMC between January and December 2015 who received NIV as the treatment for respiratory failure were included in this study. Outcomes of patients aged ≥85 years were compared with lower ages. The expected intrahospital mortality was calculated through the Simplified Acute Physiology Score (SAPS) II and compared with the observed mortality.

RESULTS: The mean age was 87.9±2.9 years; the M:F ratio was approximately 1:3. The average SAPS II was 50.1±13.7. The NIV failure rate was 21.7%. The mortality in the very old group was not statistically different from the younger group (20% vs 25.6%; d=5.6%; 95% CI -8% to 19%; p=0.404). The observed mortality was significantly lower than the expected mortality in both the group ≥85 (20.0% vs 43.4%, difference=23.4%; 95% CI 5.6% to 41.1%, p=0.006) and the younger group (25.6% vs 38.5%, difference=12.9%; 95% CI -0.03% to 25.8%, p=0.046). In both age groups, patients treated with NIV for chronic obstructive pulmonary disease had lower mortalities than those treated for other illnesses, although this was statistically significant only in the younger group.

CONCLUSION: In very old patients, when used with correct indications, NIV was associated with mortality similar to younger patients. Patients receiving NIV had lower than expected mortality in all age groups.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Montoneri G, Noto P, Trovato FM, et al. Outcomes of non-invasive ventilation in 'very old' patients with acute respiratory failure: a retrospective study. Emerg Med J. 2019. PMID: 30944114. doi:10.1136/emermed-2018-207563

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。